Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-01-14

FDA Approved: ETODOLAC — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)

View source ↗

Summary

FDA approved a supplemental application for etodolac filed by Taro Pharmaceuticals U.S.A., Inc., authorizing changes to labeling and/or manufacturing for this g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Etodolac (Etodolac)

Snippet

SUPPL AP for ETODOLAC (ETODOLAC)